Bionorica SE
20
0
0
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
5.0%
1 terminated/withdrawn out of 20 trials
94.4%
+7.9% vs industry average
55%
11 trials in Phase 3/4
12%
2 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
Role: collaborator
Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol
Role: collaborator
Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
Role: lead
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
Role: collaborator
Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19
Role: collaborator
Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting
Role: collaborator
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
Role: lead
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
Role: lead
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis
Role: lead
BX-1 in Spasticity Due to Multiple Sclerosis
Role: lead
Study of Imupret Application in the Technology of Delayed Prescription of Antibiotics in Patients With Acute Tonsillitis
Role: collaborator
Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52
Role: collaborator
Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)
Role: lead
Sinupret Extract Coated Tablets in Chronic Rhinosinusitis
Role: lead
Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs
Role: lead
Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS
Role: lead
Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic Rhinosinusitis
Role: lead
Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)
Role: lead
Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis
Role: lead
Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome
Role: lead
All 20 trials loaded